{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:31:34Z","timestamp":1793637094772,"version":"4.5.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003827","name":"NKFIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009232","name":"University of Debrecen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.rpth.2026.106891","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:11:18Z","timestamp":1785251478000},"page":"106891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Beyond complement: comprehensive assessment of factor XIII plasma dynamics and genetics in atypical hemolytic uremic syndrome"],"prefix":"10.1016","volume":"10","author":[{"given":"No\u00e9mi","family":"Janszky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"Katona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Sinkovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorottya","family":"Csuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Haris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velibor","family":"Tasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Abazi-Emini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gere","family":"Sunder-Plassmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvie Rajnochov\u00e1","family":"Bloud\u00ed\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Proh\u00e1szka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Muszbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Szil\u00e1gyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106891_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5551\/jat.RV17026","article-title":"Pathogenesis of Atypical Hemolytic Uremic Syndrome","volume":"26","author":"Yoshida","year":"2019","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.rpth.2026.106891_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/ckj\/sfz040","article-title":"An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy","volume":"12","author":"Aigner","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.rpth.2026.106891_bib3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.kint.2024.05.021","article-title":"An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working Group","volume":"106","author":"Nester","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.rpth.2026.106891_bib4","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.rpth.2026.106891_bib5","first-page":"71","article-title":"Interaction between the coagulation and complement system","volume":"632","author":"Amara","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.rpth.2026.106891_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.rpth.2026.106891_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106891_bib8","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1681\/ASN.2018070759","article-title":"Genetic analysis of 400 patients refines understanding and implicates a new gene in atypical hemolytic uremic syndrome","volume":"29","author":"Bu","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.rpth.2026.106891_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1681\/ASN.2013050453","article-title":"Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome","volume":"25","author":"Bu","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.rpth.2026.106891_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.103012","article-title":"Plasminogen mutation-associated thrombotic microangiopathy and role of anticoagulation: a single institution case series","volume":"9","author":"Agarwal","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106891_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40560-014-0061-4","article-title":"Complement, thrombotic microangiopathy and disseminated intravascular coagulation","volume":"2","author":"Kurosawa","year":"2014","journal-title":"J Intensive Care"},{"key":"10.1016\/j.rpth.2026.106891_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/1076029607304723","article-title":"The homozygous Leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies","volume":"15","author":"Sucker","year":"2009","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.rpth.2026.106891_bib13","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1182\/blood-2013-10-533596","article-title":"Interaction of factor XIII subunits","volume":"123","author":"Katona","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106891_bib14","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood-2016-04-712323","article-title":"The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues \u03b3390-396 and the FXIII-B subunits","volume":"128","author":"Byrnes","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106891_bib15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1538-7836.2012.04674.x","article-title":"Complement activation in thrombotic thrombocytopenic purpura","volume":"10","author":"R\u00e9ti","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106891_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-0037-1613798","article-title":"A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2)","volume":"83","author":"Katona","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106891_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4939-7196-1_22","article-title":"Assessment of factor XIII","volume":"1646","author":"Muszbek","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.rpth.2026.106891_bib18","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.rpth.2026.106891_bib19","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"Sanger","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rpth.2026.106891_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ajhg.2008.06.024","article-title":"Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data","volume":"83","author":"Li","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rpth.2026.106891_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molimm.2016.01.003","article-title":"Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome","volume":"71","author":"Szarvas","year":"2016","journal-title":"Mol Immunol"},{"key":"10.1016\/j.rpth.2026.106891_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejim.2019.11.007","article-title":"Preemptive plasma therapy prevents atypical hemolytic uremic syndrome relapse in kidney transplant recipients","volume":"73","author":"Aigner","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.rpth.2026.106891_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.xkme.2019.12.004","article-title":"Successful pregnancies during ongoing eculizumab therapy in two patients with complement-mediated thrombotic microangiopathy","volume":"2","author":"Haninger-Vacariu","year":"2020","journal-title":"Kidney Med"},{"issue":"11","key":"10.1016\/j.rpth.2026.106891_bib24","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00431-020-03666-9","article-title":"Molecular basis and outcomes of atypical haemolytic uraemic syndrome in Czech children","volume":"179","author":"\u0160tolbov\u00e1","year":"2020","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.rpth.2026.106891_bib25","first-page":"810","article-title":"Molecular subunits and transamidase activity of factor XIII in patients with deep vein thrombosis","volume":"113","author":"K\u0142oczko","year":"1986","journal-title":"Folia Haematol Int Mag Klin Morphol Blutforsch"},{"key":"10.1016\/j.rpth.2026.106891_bib26","first-page":"519","article-title":"Plasma fibrin clots of pulmonary embolism patients present increased amounts of factor XIII and alpha2-antiplasmin at 3 months\u2019 anticoagulation since the acute phase","volume":"71","author":"Zabczyk","year":"2020","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.rpth.2026.106891_bib27","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1055\/s-0039-1681116","article-title":"Changes in platelet functions, coagulation and fibrinolysis in uncomplicated cases of acute myocardial infarction","volume":"42","author":"Bjerre Knudsen","year":"1979","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106891_bib28","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1055\/s-0038-1651904","article-title":"Reduction of coagulation factor XIII concentration in patients with myocardial infarction, cerebral infarction, and other thromboembolic disorders","volume":"38","author":"Alkjaersig","year":"1977","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106891_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.blre.2011.03.001","article-title":"An update of the mutation profile of Factor 13 A and B genes","volume":"25","author":"Biswas","year":"2011","journal-title":"Blood Rev"},{"key":"10.1016\/j.rpth.2026.106891_bib30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1365-2141.2002.03707.x","article-title":"Factor XIII A-subunit concentration predicts outcome in stroke subjects and vascular outcome in healthy, middle-aged men","volume":"118","author":"Kohler","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2026.106891_bib31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0037-1616249","article-title":"Coagulation factor XIII B subunit antigen, FXIIIVal34Leu genotype and ischaemic stroke in South Asians","volume":"93","author":"Kain","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106891_bib32","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1160\/TH03-07-0031","article-title":"Role of blood coagulation factor XIII in patients with acute pulmonary embolism: correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness","volume":"90","author":"Kucher","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106891_bib33","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1172\/JCI75386","article-title":"Factor XIII activity mediates red blood cell retention in venous thrombi","volume":"124","author":"Aleman","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rpth.2026.106891_bib34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1182\/blood.2023022042","article-title":"Reciprocal stabilization of coagulation factor XIII-A and -B subunits is a determinant of plasma FXIII concentration","volume":"143","author":"Byrnes","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106891_bib35","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/01.ATV.19.8.2012","article-title":"Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals: relation to sex, age, smoking, and hypertension","volume":"19","author":"Ari\u00ebns","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2026.106891_bib36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2125.2012.04172.x","article-title":"Pharmacokinetic predictions for patients with renal impairment: focus on peptides and protein drugs","volume":"74","author":"Czock","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rpth.2026.106891_bib37","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.3390\/ijms21228426","article-title":"Terminal phase components of the clotting cascade in patients with end-stage renal disease undergoing hemodiafiltration or hemodialysis treatment","volume":"21","author":"P\u00e9nzes","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rpth.2026.106891_bib38","article-title":"A comparative study on the haemostatic changes in kidney failure patients: pre- and post- haemodialysis and haemodiafiltration","volume":"242","author":"Caruana","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106891_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014294","article-title":"Blood coagulation system in patients with chronic kidney disease: a prospective observational study","volume":"7","author":"Huang","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.rpth.2026.106891_bib40","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1681\/ASN.V1271549","article-title":"The microinflammatory state in uremia: causes and potential consequences","volume":"12","author":"Kaysen","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.rpth.2026.106891_bib41","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/cei.12426","article-title":"Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission","volume":"181","author":"Volokhina","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rpth.2026.106891_bib42","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1182\/blood.V87.7.2769.bloodjournal8772769","article-title":"Type I factor XIII deficiency is caused by a genetic defect of its b subunit: insertion of triplet AAC in exon III leads to premature termination in the second Sushi domain","volume":"87","author":"Izumi","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106891_bib43","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1111\/hae.13233","article-title":"Comparison of F13A1 gene mutations in 73 patients treated with recombinant FXIII-A2","volume":"23","author":"Iva\u0161kevi\u010dius","year":"2017","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106891_bib44","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3324\/haematol.2009.017210","article-title":"Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function","volume":"95","author":"Ivaskevicius","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2026.106891_bib45","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/humu.23041","article-title":"Coagulation factor XIIIA subunit missense mutations affect structure and function at the various steps of factor XIII action","volume":"37","author":"Thomas","year":"2016","journal-title":"Hum Mutat"},{"key":"10.1016\/j.rpth.2026.106891_bib46","first-page":"512","article-title":"Fetal fractures in an infant with maternal Ehlers-Danlos syndrome, CCDC134 pathogenic mutation and a negative genetic test for osteogenesis imperfecta","volume":"8","author":"Holick","year":"2021","journal-title":"Children (Basel)"},{"key":"10.1016\/j.rpth.2026.106891_bib47","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.3390\/jcm9113402","article-title":"Deciphering the genetics of primary angioedema with normal levels of C1 inhibitor","volume":"9","author":"Loules","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.rpth.2026.106891_bib48","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1182\/blood.2020009280","article-title":"Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study","volume":"137","author":"Fakhouri","year":"2021","journal-title":"Blood"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926035491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926035491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:51:24Z","timestamp":1790164284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926035491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2475037926035491"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106891","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond complement: comprehensive assessment of factor XIII plasma dynamics and genetics in atypical hemolytic uremic syndrome","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106891"}}